Complications of pazopanib in metastatic renal cell carcinoma (mRCC) in a single tertiary centre: a case series

被引：0
|
作者：
Alagappan, K. [1 ]
Nasuha, N. A. [1 ]
机构：
[1] Hosp Raja Perempuan Zainab II, Kota Bahru, Kelantan, Malaysia
来源：
BJU INTERNATIONAL | 2019年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
C-10033
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
    Hutson, Thomas E.
    Davis, Ian D.
    Machiels, Jean-Pascal H.
    De Souza, Paul L.
    Rottey, Sylvie
    Hong, Bao-fa
    Epstein, Richard J.
    Baker, Katherine L.
    McCann, Lauren
    Crofts, Theresa
    Pandite, Lini
    Figlin, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 475 - 480
  • [32] Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?
    Bukowski, Ronald M.
    CURRENT ONCOLOGY REPORTS, 2010, 12 (02) : 77 - 79
  • [33] Pazopanib (p) or sorafenib (s) + radium-223 (rad) in metastatic renal cell carcinoma (mrcc) with bone metastases (bm)
    Bosse, D.
    McKay, R. R.
    Gray, K. P.
    Michaelson, M. D.
    Sleeper, C.
    Walsh, M.
    Krajewski, K. M.
    Jacene, H.
    Bellmunt, J.
    Pomerantz, M. M.
    Harshman, L. C.
    Choueiri, T. K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Efficacy and safety of pazopanib as a subsequent treatment after failure of other targeted agents in patients with metastatic renal cell carcinoma (mRCC).
    Tan, Jiahuai
    Heilbrun, Lance K.
    Fontana, Joseph A.
    Smith, Daryn
    Heath, Elisabeth I.
    Baranowski, Karen
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [35] Real-word evidence in patients treated with pazopanib for advanced/metastatic renal cell carcinoma (mRCC): The APOLON study.
    Thiery-Vuillemin, Antoine
    Barthelemy, Philippe
    Lebret, Thierry
    Bigot, Pierre
    Stein, Ulrich
    Dourthe, Louis Marie
    Longo, Raffaele
    De La Cruz, Jeannine
    Sevaux, Sandra
    Tindel, Malka
    Albiges, Laurence
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [36] Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
    Rossetti, Sabrina
    D'Aniello, Carmine
    Iovane, Gelsomina
    Scagliarini, Sarah
    Laterza, Maria M.
    De Vita, Fernando
    Savastano, Clementina
    Carteni, Giacomo
    Porricelli, Maria A.
    Berretta, Massimiliano
    Pisconti, Salvatore
    Facchini, Gaetano
    Cavaliere, Carla
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [37] Rare metastatic sites of renal cell carcinoma: a case series
    Singla, Anurag
    Sharma, Umesh
    Makkar, Arun
    Masood, Pirzada Faisal
    Goel, Hemant Kumar
    Sood, Rajeev
    Ahuja, Arvind
    Singh, Ravikant
    PAN AFRICAN MEDICAL JOURNAL, 2022, 42
  • [38] Rare metastatic sites of renal cell carcinoma: a case series
    Ngooi, Ming Soen
    Wong, Xing
    Salauddin, Syahril Anuar
    Ghazali, Hamid Hj
    BJU INTERNATIONAL, 2024, 134 : 14 - 14
  • [39] Metastatic Renal Cell Carcinoma to the Sinonasal Cavity: A Case Series
    Remenschneider, Aaron K.
    Sadow, Peter M.
    Lin, Derrick T.
    Gray, Stacey T.
    JOURNAL OF NEUROLOGICAL SURGERY REPORTS, 2013, 74 (02) : 67 - 72
  • [40] Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with pazopanib after progression on other targeted therapies (TT): A single-institution experience
    Matrana, Marc Ryan
    Shetty, Aditya V.
    Atkinson, Bradley J.
    Xiao, Lianchun
    Corn, Paul G.
    Millikan, Randall E.
    Jonasch, Eric
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345